Professor Dimitrios Lamprou (Ph.D. MBA) is a subject matter expert in emerging technologies for drug delivery systems and medical implants. He is the author of over 170 peer-reviewed publications and of over 450 conference abstracts, has over 200 Invited talks in institutions and conferences across the world, and has secure Funding in excess of £5M. Dimitrios, has been recognized as world leader in 3D Printing & Microfluidics. PubMed-based algorithms placed him in the top 0.01% of scholars in the world writing about Printing and in the top 0.07% of scholars in the world writing about microfluidics, over the past 10 years. Dimitrios, has also been named in the Stanford list of World's Top 2% of scientists, for several consecutive years, for his research in Pharmaceutics and Biomedical Engineering. His research and academic leadership have been recognized in a range of awards, including the Royal Pharmaceutical Society (RPS) Science Award, Scottish Universities Life Sciences Alliance (SULSA) Leaders Scheme Award, and Doctor Honoris Causa Award by Semmelweis University (Hungary).

My research is committed to developing a 3D liver model to better understand the secondary effects of anticancer agents. By investigating the link between pharmaco-toxicity and genotype-phenotype interactions, this work aims to improve patient follow-up and advance personalized medical care.